Hatem Azim

Dr. Hatem Azim is Chief Medical Officer of Emergence Therpeutics. He previously served as Head of Oncology Early Clinical Development at Pierre Fabre. Prior to this, Dr. Azim held the role of Vice President, Head of Clinical Development at Innate Pharma. Dr. Azim holds a Medical Degree from Cairo University, a Master’s degree in Oncology from the University of Newcastle Upon Tyne and a PhD from the Université Libre De Bruxelles. He is a Breast Cancer Medical Oncologist with strong academic background, having worked for many years at Jules Bordet Institute in Brussels after finishing his oncology training. He is highly published with more than 130 research papers and 10 book chapters. Dr. Azim has served as member of several international guideline committees and has been invited as faculty member on numerous occasions including at the annual conferences of the European Society for Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). He was previously awarded the ASCO Merit Award and the University of Padova Breast Cancer Award in recognition of his work in the oncology field.